Medical Equipment

Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at King Chulalongkorn Memorial Hospital, Bangkok, Thailand
Therapy Equipment

Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at King Chulalongkorn Memorial Hospital, Bangkok, Thailand

Palo Alto, Calif., July 9, 2019 /PRNewswire/ -- Varian (NYSE: VAR) celebrated the installation of the cyclotron for its ProBeam® Compact single-room proton therapy system at the King Chulalongkorn Memorial Hospital in Bangkok, Thailand on June 20, 2019. HRH Princess Maha Chakri Sirindhorn presided over the rigging ceremony. The cyclotron is a core piece of equipment of the ProBeam proton therapy...

Read More »
Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at King Chulalongkorn Memorial Hospital, Bangkok, Thailand
Therapy Equipment

Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at King Chulalongkorn Memorial Hospital, Bangkok, Thailand

Palo Alto, Calif., July 9, 2019 /PRNewswire/ -- Varian (NYSE: VAR) celebrated the installation of the cyclotron for its ProBeam® Compact single-room proton therapy system at the King Chulalongkorn Memorial Hospital in Bangkok, Thailand on June 20, 2019. HRH Princess Maha Chakri Sirindhorn presided over the rigging ceremony. The cyclotron is a core piece of equipment of the ProBeam proton therapy...

Read More »
Medical Equipment

Bio-Techne's New Exosome-based Liquid Biopsies Helping to Advance Personalized Care in Lung Cancer Diagnostics

Minneapolis, May 28, 2019 /PRNewswire/ -- Bio-Techne today announced the publication of a recent validation study demonstrating that the proprietary exosome-based liquid biopsy tests from Bio-Techne's Exosome Diagnostics brand may be used to assess the mutational status of the Epidermal Growth Factor Receptor (EGFR) gene in patients with non-small cell lung cancer (NSCLC). The data from this...

Read More »
Medical Equipment

Bio-Techne's New Exosome-based Liquid Biopsies Helping to Advance Personalized Care in Lung Cancer Diagnostics

Minneapolis, May 28, 2019 /PRNewswire/ -- Bio-Techne today announced the publication of a recent validation study demonstrating that the proprietary exosome-based liquid biopsy tests from Bio-Techne's Exosome Diagnostics brand may be used to assess the mutational status of the Epidermal Growth Factor Receptor (EGFR) gene in patients with non-small cell lung cancer (NSCLC). The data from this...

Read More »

All Topics